Ilant Health, an AI-powered value-based obesity treatment startup working with employers and health plans to deliver clinical outcomes and reduce the total cost of care, raised $15 million in Series A funding, bringing its total funding to over $22 million to date.
Cornucopian Capital led the investment round with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, as well as existing investors Celtic, LifeX, and AlphaLab.
Ilant Health is an obesity and cardiometabolic health company focused on increasing access to treatment while reducing the total cost of care for employers and payers through value-based care. Ilant Health provides the single front door for individuals with obesity, delivering end-to-end evidence-based solutions (bariatric surgery, medication, intense behavioral therapy) through a technology-enabled and analytics-driven obesity medicine practice.
“We believe the next generation of category-defining companies will be those that deliver outcomes as a service, not just tools or access,” said Aryeh Ganz, Founder and Managing Partner of Cornucopian Capital.
“Ilant is applying that model to one of the most important and costly areas in healthcare. The company understands that the future of obesity and cardiometabolic care will not be defined by access to a single class of drugs, but by the ability to deliver the right care to the right patient at the right time. Their model aligns clinical rigor with economic value in a way that we believe will define this category over the next decade,” added Aryeh Ganz.
Digital health companies, including value-based obesity treatment startups, have secured more than $180 billion in funding to date, according to our recent Funding Database.
More recently, The Path, an AI-powered mental wellness therapy app, raised $14.3 million in Seed funding led by Prime Movers Lab with participation from Apolo Anton Ohno, Deontay Wilder, Designer Fund, and others.
In another deal, Lucis, an AI-powered personalized health guidance companion app, raised a $20 million Series A, led by Singular, with participation from General Catalyst, Y Combinator, and angels including investors behind Runna, Céline Lazorthes (Resilience), and Manu Lecomte.